Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA)

results from a double-blind, phase 3, randomised controlled trial

Amit M Oza, Ursula A Matulonis, Susanne Malander, Stacie Hudgens, Jalid Sehouli, Josep M Del Campo, Dominique Berton-Rigaud, Susana Banerjee, Giovanni Scambia, Jonathan S Berek, Bente Lund, Anna V Tinker, Felix Hilpert, Isabel Palacio Vázquez, Véronique D'Hondt, Benedict Benigno, Diane Provencher, Joseph Buscema, Shefali Agarwal, Mansoor Raza Mirza

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

16 Citationer (Scopus)
OriginalsprogEngelsk
TidsskriftThe Lancet. Oncology
Vol/bind19
Udgave nummer8
Sider (fra-til)1117-1125
Antal sider9
ISSN1470-2045
DOI
StatusUdgivet - 2018

Fingerprint

Ovarian Neoplasms
Randomized Controlled Trials
Placebos
Quality of Life
Platinum
Disease-Free Survival
Poisons
Therapeutics
Random Allocation
Neutropenia
Thrombocytopenia
Nausea
Anemia
niraparib
Germ-Line Mutation
Genetic Testing
Israel
Canada
Neoplasms
Histology

Citer dette

Oza, Amit M ; Matulonis, Ursula A ; Malander, Susanne ; Hudgens, Stacie ; Sehouli, Jalid ; Del Campo, Josep M ; Berton-Rigaud, Dominique ; Banerjee, Susana ; Scambia, Giovanni ; Berek, Jonathan S ; Lund, Bente ; Tinker, Anna V ; Hilpert, Felix ; Vázquez, Isabel Palacio ; D'Hondt, Véronique ; Benigno, Benedict ; Provencher, Diane ; Buscema, Joseph ; Agarwal, Shefali ; Mirza, Mansoor Raza. / Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA) : results from a double-blind, phase 3, randomised controlled trial. I: The Lancet. Oncology. 2018 ; Bind 19, Nr. 8. s. 1117-1125.
@article{fd8648ccc6394225ac475729d875128c,
title = "Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial",
author = "Oza, {Amit M} and Matulonis, {Ursula A} and Susanne Malander and Stacie Hudgens and Jalid Sehouli and {Del Campo}, {Josep M} and Dominique Berton-Rigaud and Susana Banerjee and Giovanni Scambia and Berek, {Jonathan S} and Bente Lund and Tinker, {Anna V} and Felix Hilpert and V{\'a}zquez, {Isabel Palacio} and V{\'e}ronique D'Hondt and Benedict Benigno and Diane Provencher and Joseph Buscema and Shefali Agarwal and Mirza, {Mansoor Raza}",
note = "Copyright {\circledC} 2018 Elsevier Ltd. All rights reserved.",
year = "2018",
doi = "10.1016/S1470-2045(18)30333-4",
language = "English",
volume = "19",
pages = "1117--1125",
journal = "Lancet Oncology",
issn = "1470-2045",
publisher = "TheLancet Publishing Group",
number = "8",

}

Oza, AM, Matulonis, UA, Malander, S, Hudgens, S, Sehouli, J, Del Campo, JM, Berton-Rigaud, D, Banerjee, S, Scambia, G, Berek, JS, Lund, B, Tinker, AV, Hilpert, F, Vázquez, IP, D'Hondt, V, Benigno, B, Provencher, D, Buscema, J, Agarwal, S & Mirza, MR 2018, 'Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial', The Lancet. Oncology, bind 19, nr. 8, s. 1117-1125. https://doi.org/10.1016/S1470-2045(18)30333-4

Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA) : results from a double-blind, phase 3, randomised controlled trial. / Oza, Amit M; Matulonis, Ursula A; Malander, Susanne; Hudgens, Stacie; Sehouli, Jalid; Del Campo, Josep M; Berton-Rigaud, Dominique; Banerjee, Susana; Scambia, Giovanni; Berek, Jonathan S; Lund, Bente; Tinker, Anna V; Hilpert, Felix; Vázquez, Isabel Palacio; D'Hondt, Véronique; Benigno, Benedict; Provencher, Diane; Buscema, Joseph; Agarwal, Shefali; Mirza, Mansoor Raza.

I: The Lancet. Oncology, Bind 19, Nr. 8, 2018, s. 1117-1125.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA)

T2 - results from a double-blind, phase 3, randomised controlled trial

AU - Oza, Amit M

AU - Matulonis, Ursula A

AU - Malander, Susanne

AU - Hudgens, Stacie

AU - Sehouli, Jalid

AU - Del Campo, Josep M

AU - Berton-Rigaud, Dominique

AU - Banerjee, Susana

AU - Scambia, Giovanni

AU - Berek, Jonathan S

AU - Lund, Bente

AU - Tinker, Anna V

AU - Hilpert, Felix

AU - Vázquez, Isabel Palacio

AU - D'Hondt, Véronique

AU - Benigno, Benedict

AU - Provencher, Diane

AU - Buscema, Joseph

AU - Agarwal, Shefali

AU - Mirza, Mansoor Raza

N1 - Copyright © 2018 Elsevier Ltd. All rights reserved.

PY - 2018

Y1 - 2018

U2 - 10.1016/S1470-2045(18)30333-4

DO - 10.1016/S1470-2045(18)30333-4

M3 - Journal article

VL - 19

SP - 1117

EP - 1125

JO - Lancet Oncology

JF - Lancet Oncology

SN - 1470-2045

IS - 8

ER -